검색어 : 통합검색[Clinical Trials as Topic.]
총 3,268건 중 1,000건 출력
, 1/100 페이지
-
1
- Clinical Trials on Children Adopted as New ICH Topic
- ; ; (Pharma Japan: Japan drug industry news, v.1615, 1998, pp.12)
-
2
- Topic: <i>AS08-Treatment/AS08g-Clinical trials - Phase II-III</i> : EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM
- Peterlin, P.; Turlure, P.; Chevallier, P.; Gourin, M.-P.; Dumas, P.-Y.; Thepot, S.; Berceanu, A.; Park, S.; Hospital, M.-A.; Cluzeau, T.; Torregrossa-Diaz, J.-M.; Devron, L.; Sapena, R.; Chermat, F.; Dimicoli-Salazar, S.; Fenaux, P.; ; (Leukemia research, v.108, 2021, pp.106681.51)
-
3
- OP003 Topic: AS04-Emerging Sciences, Methodologies, Big Data and Technology: A DECISION-MAKING GRID FOR MULTIPLE CLINICAL TRIALS
- Beth Kalvas, Laura; Asaro, L.A.; Wypij, D.; Curley, M.A.Q.; University of Pennsylvania School of Nursing, Philadelphia, United States of America; Boston Children’s Hospital, Boston, United States of America; Boston Children’s Hospital, Boston, United States of America; University of Pennsylvania School of Nursing, Philadelphia, United States of America; (Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, v.25, 2024, pp.e1-e2)
-
4
- Streamlining cardiovascular clinical trials to improve efficiency and generalisability
- Zannad, Faiez; Pfeffer, Marc A; Bhatt, Deepak L; Bonds, Denise E; Borer, Jeffrey S; Calvo-Rojas, Gonzalo; Fiore, Louis; Lund, Lars H; Madigan, David; Maggioni, Aldo Pietro; Meyers, Catherine M; Rosenberg, Yves; Simon, Tabassome; Stough, Wendy Gattis; Zalewski, Andrew; Zariffa, Nevine; Temple, Robert; Clinical Investigation Center, Centre Hospitalier Universitaire de Nancy, , Nancy, France; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, , Boston, Massachusetts, USA; Brigham and Women's Heart and Vascular Center, Harvard Medical School, , Boston, Massachusetts, USA; National Heart, Lung, and Blood Institute, National Institutes of Health, , Bethesda, , Maryland, USA; The Howard Gilman Institute, , New York, New York, USA; Department of Clinical Pharmacology, Hospital Clà í nic, University of Barcelona, , Barcelona, Spain; Department of Veterans Affairs, Cooperative Studies Program, , Boston, Massachusetts, USA; Department of Medicine, Unit of Cardiology, Karolinska Institute, , Stockholm, Sweden; Department of Statistics, Columbia University, , New York, New York, USA; ANMCO Research Center, , Florence, Italy; National Center for Complementary and Integrative Health, National Institutes of Health, , Bethesda, , Maryland, USA; Nat; (Heart : official journal of the British Cardiac Society, v.103, 2017, pp.1156-1162)
-
5
- Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
- Atkins, Michael B; Abu-Sbeih, Hamzah; Ascierto, Paolo A; Bishop, Michael R; Chen, Daniel S; Dhodapkar, Madhav; Emens, Leisha A; Ernstoff, Marc S; Ferris, Robert L; Greten, Tim F; Gulley, James L; Herbst, Roy S; Humphrey, Rachel W; Larkin, James; Margolin, Kim A; Mazzarella, Luca; Ramalingam, Suresh S; Regan, Meredith M; Rini, Brian I; Sznol, Mario; Georgetown Lombardi Comprehensive Cancer Center , Washington , District of Columbia , USA; University of Missouri Kansas City , Kansas City , Missouri , USA; Istituto Nazionale Tumori IRCCS Fondazione 'G Pascale' , Napoli , Italy; The David and Etta Jonas Center for Cellular Therapy, University of Chicago , Chicago , Illinois , USA; Engenuity Life Sciences , Burlingame , California , USA; Center for Cancer Immunology, Winship Cancer Institute at Emory University , Atlanta , Georgia , USA; UPMC Hillman Cancer Center , Pittsburgh , Pennsylvania , USA; DCTD/DTP-IOB , ImmunoOncology Branch, NCI , Bethesda , Maryland , USA; UPMC Hillman Cancer Center , Pittsburgh , Pennsylvania , USA; Gastrointestinal Malignancies Section , National Cancer Institue CCR Liver Program ,; (Journal for immunotherapy of cancer, v.10, 2022, pp.e005413)
-
6
- Challenges of stem cell therapies in companion animal practice
- Kang, Min-Hee; Park, Hee-Myung; Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University; Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University; (Journal of veterinary science, v.21, 2020, pp.42.1-42.22)
-
7
- 한국 중년여성의 비약물적 우울중재연구: 체계적 문헌고찰
- 채명옥; 전해옥; 김아린; 청주대학교 간호학과; 청주대학교 간호학과; 청주대학교 간호학과; (한국산학기술학회논문지 = Journal of the Korea Academia-Industrial cooperation Society, v.17, 2016, pp.638-651)
-
8
- Topic: AS08-Treatment/AS08f-Clinical trials - Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES
- Savona, M.; Mccloskey, J.; Griffiths, E.; Yee, K.; Zeidan, A.; Al-Kali, A.; Deeg, H.J.; Patel, P.; Sabloff, M.; Keating, M.-M.; Zhu, N.; Gabrail, N.; Fazal, S.; Maly, J.; Odenike, O.; Kantarjian, H.; Dezern, A.; O’Connell, C.; Roboz, G.; Busque, L.; Buckstein, R.; Amin, H.; Randhawa, J.; Leber, B.; Dao, K.-H.; Sano, Y.; Mirakhur, B.; Keer, H.; Garcia-Manero, G.; ; (Leukemia research, v.128, 2023, pp.107271)
-
9
- Topic: AS08-Treatment/AS08f-Clinical trials - Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI)
- Watts, J.; Smith, B.; Bradley, T.; Skikne, B.; Mendler, J.; Klimek, V.; Thomassen, A.; Stopcyzinski, T.; Chen, S.-C.; Run, F.; Anderson, I.; Moncrief, A.; Madhu, S.; Sochacki, A.; Kishtagari, A.; Strickland, S.; Byrne, M.; Ayers, G.; Mohan, S.; Moyo, T.; Savona, M.; ; (Leukemia research, v.128, 2023, pp.107272)
-
10
- Topic: <i>AS08-Treatment/AS08g-Clinical trials - Phase II-III</i> : PHASE 3 VERONA STUDY ASSESSING THE SAFETY AND EFFICACY OF VENETOCLAX WITH AZACITIDINE IN PATIENTS WITH NEWLY DIAGNOSED HIGHER-RISK MYELODYSPLASTIC SYNDROMES
- Zeidan, A.M.; Garcia, J.; Fenaux, P.; Platzbecker, U.; Miyazaki, Y.; Xiao, Z.; Zhou, Y.; Naqvi, K.; Kye, S.; Manero, G. Garcia; ; (Leukemia research, v.108, 2021, pp.106681.52)
QUICK MENU
